| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| CD5-targeted CAR-T cells therapy(Senlang Biotechnology) | Phase 2 Clinical | Hebei Senlang Biological Technology Co Ltd | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 詳細 | |
| CD5/CD7-Specific CAR-T Cells therapy(Essen Biotech) | BAH246; BAH-246; EB-BH2026 | Phase 2 Clinical | Essen Biotech | Central Nervous System Diseases; Leukemia, Prolymphocytic, T-Cell; Leukemia, T-Cell; Lymphoma, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 詳細 |
| CD5 CAR T Cells therapy(Beijing GoBroad Hospital) | Phase 2 Clinical | Beijing GoBroad Hospital | Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 詳細 | |
| MB-105(March Biosciences) | MB-105(March Biosciences) | Phase 2 Clinical | March Biosciences Inc | Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 詳細 |
| anti-CD5 CAR T-cell therapy (Beijing Boren Hospital) | Phase 1 Clinical | Beijing Gao Boren Hospital Co Ltd | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 詳細 | |
| CD5CAR | CD5CAR | Phase 1 Clinical | iCell Gene Therapeutics LLC | Lymphoma, Non-Hodgkin; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 詳細 |
| CT-125A | CT-125A; RD-125 | Phase 1 Clinical | Nanjing Iaso Biotherapeutics Co Ltd | Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Plasmablastic Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 詳細 |
| CD5 Targeting Chimeric Antigen Receptor NK Cells (CAR-NK) thrapy(Precision Biotechnology) | Phase 1 Clinical | Chongqing Precision Biotechnology Co Ltd | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 詳細 | |
| CD5 CAR T-cells therapy(Yake Biotechnology) | Phase 1 Clinical | Shanghai YaKe Biotechnology Co Ltd | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 詳細 | |
| AB-205 (Artiva Biotherapeutics/GC Cell) | CD5 CAR-NK; GCC-2005; GL-205; GCC2005 | Phase 1 Clinical | GC Cell Corp | Lymphoma, T-Cell | 詳細 |
| Autologous CAR-T cell therapy(Vittoria Biotherapeutics) | VIPER-101; Senza5 CART5; VIPER101 | Phase 1 Clinical | Vittoria Biotherapeutics Inc | Lymphoma, T-Cell | 詳細 |
| CD5 CAR T-Cells (Baylor College of Medicine) | Phase 1 Clinical | Baylor College Of Medicine | Lymphoma, Non-Hodgkin; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 詳細 | |
| CD5 CAR-T Therapy(Xuanwu Hospital) | Phase 1 Clinical | Xuanwu Hospital Of Capital Medical University | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 詳細 |